{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:50Z","timestamp":1790115950961,"version":"4.0.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12664-025-01886-1","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T10:58:23Z","timestamp":1766660303000},"page":"838-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From pain relief to mucosal grief: A comprehensive review of NSAID enteropathy"],"prefix":"10.1007","volume":"45","author":[{"given":"Harsh","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanisha","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-2099","authenticated-orcid":false,"given":"Manjeet Kumar","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"1886_CR1","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2165\/00003495-200464230-00001","volume":"64","author":"G Onder","year":"2004","unstructured":"Onder G, Pellicciotti F, Gambassi G, Bernabei R. Nsaid-related psychiatric adverse events: who is at risk? Drugs. 2004;64:2619\u201327. https:\/\/doi.org\/10.2165\/00003495-200464230-00001.","journal-title":"Drugs."},{"key":"1886_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a117469","volume":"141","author":"WE Smalley","year":"1995","unstructured":"Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539\u201345. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a117469.","journal-title":"Am J Epidemiol."},{"key":"1886_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","volume":"128","author":"L Maiden","year":"2005","unstructured":"Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of NSAID induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128:1172\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.020.","journal-title":"Gastroenterology."},{"key":"1886_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s1542-3565(04)00619-6","volume":"3","author":"JL Goldstein","year":"2005","unstructured":"Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133\u201341. https:\/\/doi.org\/10.1016\/s1542-3565(04)00619-6.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1886_CR5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","volume":"5","author":"L Maiden","year":"2007","unstructured":"Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007;5:1040\u20135. https:\/\/doi.org\/10.1016\/j.cgh.2007.04.031.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1886_CR6","doi-asserted-by":"publisher","unstructured":"Maiden L. Capsule endoscopic diagnosis of nonsteroidal anti-inflammatory drug-induced enteropathy. J Gastroenterol. 2009;44 Suppl 19:64\u201371. https:\/\/doi.org\/10.1007\/s00535-008-2248-8.","DOI":"10.1007\/s00535-008-2248-8"},{"key":"1886_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s1542-3565(04)00603-2","volume":"3","author":"DY Graham","year":"2005","unstructured":"Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55\u20139. https:\/\/doi.org\/10.1016\/s1542-3565(04)00603-2.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1886_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/00365520701794121","volume":"43","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto T, Kudo T, Esaki M, et al. Prevalence of non-steroidal anti-inflammatory drug induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol. 2008;43:490\u20136. https:\/\/doi.org\/10.1080\/00365520701794121.","journal-title":"Scand J Gastroenterol."},{"key":"1886_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0090-6980(77)90178-2","volume":"14","author":"A Robert","year":"1977","unstructured":"Robert A, Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins. 1977;14:333\u201341. https:\/\/doi.org\/10.1016\/0090-6980(77)90178-2.","journal-title":"Prostaglandins."},{"key":"1886_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/BF01694504","volume":"22","author":"WF Fang","year":"1977","unstructured":"Fang WF, Broughton A, Jacobson ED. Indomethacin-induced intestinal inflammation. Am J Dig Dis. 1977;22:749\u201360. https:\/\/doi.org\/10.1007\/BF01694504.","journal-title":"Am J Dig Dis."},{"key":"1886_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0016-5085(81)90196-7","volume":"80","author":"BJ Whittle","year":"1981","unstructured":"Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94\u20138.","journal-title":"Gastroenterology."},{"key":"1886_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/BF00920471","volume":"17","author":"T Yamada","year":"1993","unstructured":"Yamada T, Deitch E, Specian RD, et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 1993;17:641\u201362. https:\/\/doi.org\/10.1007\/BF00920471.","journal-title":"Inflammation."},{"key":"1886_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1348-0421.1996.tb01108.x","volume":"40","author":"M Uejima","year":"1996","unstructured":"Uejima M, Kinouchi T, Kataoka K, et al. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol Immunol. 1996;40:553\u201360. https:\/\/doi.org\/10.1111\/j.1348-0421.1996.tb01108.x.","journal-title":"Microbiol Immunol."},{"key":"1886_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1476-5381.2011.01509.x","volume":"165","author":"JL Wallace","year":"2012","unstructured":"Wallace JL. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol. 2012;165:67\u201374. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01509.x.","journal-title":"Br J Pharmacol."},{"key":"1886_CR15","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","volume":"104","author":"I Bjarnason","year":"1993","unstructured":"Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832\u201347. https:\/\/doi.org\/10.1016\/0016-5085(93)90667-2.","journal-title":"Gastroenterology."},{"key":"1886_CR16","first-page":"137","volume":"3","author":"NM Davies","year":"2000","unstructured":"Davies NM, Saleh JY, Skjodt NM. Detection and prevention of NSAID-induced enteropathy. J Pharm Pharm Sci. 2000;3:137\u201355.","journal-title":"J Pharm Pharm Sci."},{"key":"1886_CR17","doi-asserted-by":"publisher","unstructured":"Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. Am J Ther. 2000;7:115\u201321. https:\/\/doi.org\/10.1097\/00045391-200007020-00008.","DOI":"10.1097\/00045391-200007020-00008"},{"key":"1886_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/cancers13040594","volume":"13","author":"J Maniewska","year":"2021","unstructured":"Maniewska J, Je\u017cewska D. Non-steroidal anti-inflammatory drugs in colorectal cancer chemoprevention.\u00a0Cancers (Basel). 2021;13:594. https:\/\/doi.org\/10.3390\/cancers13040594.","journal-title":"Cancers."},{"key":"1886_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-008-2182-9","volume":"43","author":"N Kameda","year":"2008","unstructured":"Kameda N, Higuchi K, Shiba M, et al. A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. J Gastroenterol. 2008;43:434\u201340. https:\/\/doi.org\/10.1007\/s00535-008-2182-9.","journal-title":"J Gastroenterol."},{"key":"1886_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3109\/00365529008997613","volume":"25","author":"L Aabakken","year":"1990","unstructured":"Aabakken L, Osnes M. 51Cr-ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug. Scand J Gastroenterol. 1990;25:917\u201324. https:\/\/doi.org\/10.3109\/00365529008997613.","journal-title":"Scand J Gastroenterol."},{"key":"1886_CR21","doi-asserted-by":"publisher","first-page":"40317","DOI":"10.1038\/srep40317","volume":"7","author":"X Xiao","year":"2017","unstructured":"Xiao X, Nakatsu G, Jin Y, et al. Gut microbiota mediates protection against enteropathy induced by indomethacin. Sci Rep. 2017;7:40317. https:\/\/doi.org\/10.1038\/srep40317.","journal-title":"Sci Rep."},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.5217\/ir.2017.15.4.446","volume":"15","author":"SJ Shin","year":"2017","unstructured":"Shin SJ, Noh CK, Lim SG, et al. Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res. 2017;15:446\u201355. https:\/\/doi.org\/10.5217\/ir.2017.15.4.446.","journal-title":"Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res."},{"key":"1886_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/jpet.113.207118","volume":"348","author":"M Fornai","year":"2014","unstructured":"Fornai M, Antonioli L, Colucci R, et al. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? J Pharmacol Exp Ther. 2014;348:86\u201395. https:\/\/doi.org\/10.1124\/jpet.113.207118.","journal-title":"J Pharmacol Exp Ther."},{"key":"1886_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.818877","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Xia F, Xia S, et al. NSAID-associated small intestinal injury: an overview from animal model development to pathogenesis, treatment, and prevention. Front Pharmacol. 2022;13:818877. https:\/\/doi.org\/10.3389\/fphar.2022.818877.","journal-title":"Front Pharmacol."},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1053\/j.gastro.2008.07.067","volume":"135","author":"L Laine","year":"2008","unstructured":"Laine L, Curtis SP, Langman M, et al. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology. 2008;135:1517\u201325. https:\/\/doi.org\/10.1053\/j.gastro.2008.07.067.","journal-title":"Gastroenterology."},{"key":"1886_CR26","doi-asserted-by":"publisher","first-page":"fj201800560R","DOI":"10.1096\/fj.201800560R","volume":"32","author":"S Edogawa","year":"2018","unstructured":"Edogawa S, Peters SA, Jenkins GD, et al. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J. 2018;32:fj201800560R. https:\/\/doi.org\/10.1096\/fj.201800560R.","journal-title":"FASEB J"},{"key":"1886_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00228-005-0949-y","volume":"61","author":"A Helin-Salmivaara","year":"2005","unstructured":"Helin-Salmivaara A, Huupponen R, Virtanen A, et al. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2005;61:425\u201331. https:\/\/doi.org\/10.1007\/s00228-005-0949-y.","journal-title":"Eur J Clin Pharmacol."},{"key":"1886_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00228-004-0849-6","volume":"60","author":"AD Paul","year":"2005","unstructured":"Paul AD, Chauhan CK. Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting. Eur J Clin Pharmacol. 2005;60:889\u201392. https:\/\/doi.org\/10.1007\/s00228-004-0849-6.","journal-title":"Eur J Clin Pharmacol."},{"key":"1886_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-019-01657-8","volume":"55","author":"T Watanabe","year":"2020","unstructured":"Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory druginduced small-bowel damage: a comprehensive review. J Gastroenterol. 2020;55:481\u201395. https:\/\/doi.org\/10.1007\/s00535-019-01657-8.","journal-title":"J Gastroenterol."},{"key":"1886_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0016-5085(70)80149-4","volume":"58","author":"J Wax","year":"1970","unstructured":"Wax J, Clinger WA, Varner P, et al. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology. 1970;58:772\u201380.","journal-title":"Gastroenterology."},{"key":"1886_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00204-006-0149-2","volume":"81","author":"M Jacob","year":"2007","unstructured":"Jacob M, Foster R, Sigthorsson G, et al. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch Toxicol. 2007;81:291\u20138. https:\/\/doi.org\/10.1007\/s00204-006-0149-2.","journal-title":"Arch Toxicol."},{"key":"1886_CR32","first-page":"491","volume":"62","author":"LM Lichtenberger","year":"2011","unstructured":"Lichtenberger LM, Phan T, Okabe S. Aspirin\u2019s ability to induce intestinal injury in rats is dependent on bile and can be reversed if pre-associated with phosphatidylcholine. J Physiol Pharmacol. 2011;62:491\u20136.","journal-title":"J Physiol Pharmacol."},{"key":"1886_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/gut.2007.125963","volume":"57","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Higuchi K, Kobata A, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2008;57:181\u20137. https:\/\/doi.org\/10.1136\/gut.2007.125963.","journal-title":"Gut."},{"issue":"Suppl 2","key":"1886_CR34","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2465","volume":"10","author":"A Lanas","year":"2008","unstructured":"Lanas A. Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther. 2008;10 Suppl 2:S4. https:\/\/doi.org\/10.1186\/ar2465.","journal-title":"Arthritis Res Ther."},{"key":"1886_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1163\/156856003322699582","volume":"11","author":"BJR Whittle","year":"2003","unstructured":"Whittle BJR. Nitric oxide and the gut injury induced by non-steroidal anti-inflammatory drugs. Inflammopharmacology. 2003;11:415\u201322. https:\/\/doi.org\/10.1163\/156856003322699582.","journal-title":"Inflammopharmacology."},{"key":"1886_CR36","doi-asserted-by":"publisher","first-page":"G576","DOI":"10.1152\/ajpgi.1999.276.3.G576","volume":"276","author":"H Koga","year":"1999","unstructured":"Koga H, Aoyagi K, Matsumoto T, et al. Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin. Am J Physiol. 1999;276:G576\u201382. https:\/\/doi.org\/10.1152\/ajpgi.1999.276.3.G576.","journal-title":"Am J Physiol."},{"key":"1886_CR37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","volume":"11","author":"D Maseda","year":"2020","unstructured":"Maseda D, Ricciotti E. NSAID-gut microbiota interactions. Front Pharmacol. 2020;11:1153. https:\/\/doi.org\/10.3389\/fphar.2020.01153.","journal-title":"Front Pharmacol"},{"key":"1886_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1021\/acsinfecdis.7b00139","volume":"4","author":"AP Bhatt","year":"2018","unstructured":"Bhatt AP, Gunasekara DB, Speer J, et al. Nonsteroidal anti-inflammatory drug-induced leaky gut modeled using polarized monolayers of primary human intestinal epithelial cells. ACS Infect Dis. 2018;4:46\u201352. https:\/\/doi.org\/10.1021\/acsinfecdis.7b00139.","journal-title":"ACS Infect Dis."},{"key":"1886_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5946\/ce.2012.45.2.138","volume":"45","author":"YJ Lim","year":"2012","unstructured":"Lim YJ, Yang CH. Non-steroidal anti-inflammatory drug-induced enteropathy. Clin Endosc. 2012;45:138\u201344. https:\/\/doi.org\/10.5946\/ce.2012.45.2.138.","journal-title":"Non-steroidal anti-inflammatory drug-induced enteropathy. Clin Endosc."},{"key":"1886_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jbspin.2004.10.004","volume":"72","author":"G Thi\u00e9fin","year":"2005","unstructured":"Thi\u00e9fin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine. 2005;72:286\u201394. https:\/\/doi.org\/10.1016\/j.jbspin.2004.10.004.","journal-title":"Joint Bone Spine."},{"key":"1886_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/s0140-6736(87)91075-0","volume":"2","author":"I Bjarnason","year":"1987","unstructured":"Bjarnason I, Zanelli G, Prouse P, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987;2:711\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(87)91075-0.","journal-title":"Lancet."},{"key":"1886_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/pgmj.2005.039586","volume":"82","author":"D Adebayo","year":"2006","unstructured":"Adebayo D, Bjarnason I. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J. 2006;82:186\u201391. https:\/\/doi.org\/10.1136\/pgmj.2005.039586.","journal-title":"Postgrad Med J."},{"key":"1886_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.gtc.2009.03.007","volume":"38","author":"A Lanas","year":"2009","unstructured":"Lanas A, Sope\u00f1a F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am. 2009;38:333\u201352. https:\/\/doi.org\/10.1016\/j.gtc.2009.03.007.","journal-title":"Gastroenterol Clin North Am."},{"key":"1886_CR44","first-page":"5","volume":"2","author":"NM Davies","year":"1999","unstructured":"Davies NM. Sustained release and enteric coated NSAIDs: are they really GI safe? J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 1999;2:5\u201314.","journal-title":"J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm."},{"key":"1886_CR45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00261-015-0367-2","volume":"40","author":"JM Frye","year":"2015","unstructured":"Frye JM, Hansel SL, Dolan SG, et al. NSAID enteropathy: appearance at CT and MR enterography in the age of multi-modality imaging and treatment. Abdom Imaging. 2015;40:1011\u201325. https:\/\/doi.org\/10.1007\/s00261-015-0367-2.","journal-title":"Abdom Imaging."},{"key":"1886_CR46","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.3748\/wjg.v11.i31.4861","volume":"11","author":"Y Hayashi","year":"2005","unstructured":"Hayashi Y, Yamamoto H, Kita H, et al. Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol. 2005;11:4861\u20134. https:\/\/doi.org\/10.3748\/wjg.v11.i31.4861.","journal-title":"World J Gastroenterol."},{"key":"1886_CR47","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1053\/bega.2001.0231","volume":"15","author":"S Smale","year":"2001","unstructured":"Smale S, Tibble J, Sigthorsson G, Bjarnason I. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol. 2001;15:723\u201338. https:\/\/doi.org\/10.1053\/bega.2001.0231.","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"1886_CR48","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory bowel disease. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470312\/. Accessed 15 May 2025."},{"key":"1886_CR49","unstructured":"Daley SF, Haseeb M. Celiac disease. StatPearls. StatPearls Publishing; 2025. .http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441900\/. Accessed 15 May 2025."},{"key":"1886_CR50","volume-title":"Small intestinal bacterial overgrowth","author":"SJ Sorathia","year":"2025","unstructured":"Sorathia SJ, Chippa V, Rivas JM. Small intestinal bacterial overgrowth. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546634\/."},{"key":"1886_CR51","volume-title":"StatPearls","author":"BS Bhutta","year":"2025","unstructured":"Bhutta BS, Fatima R, Aziz M. Radiation enteritis. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526032\/. Accessed 15 May 2025."},{"key":"1886_CR52","doi-asserted-by":"publisher","unstructured":"Singh A, Sahu MK, Panigrahi MK, Misra D. Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE): a tale of three decades. ACG Case Rep J. 2017;4(e44). https:\/\/doi.org\/10.14309\/crj.2017.44.","DOI":"10.14309\/crj.2017.44"},{"key":"1886_CR53","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12664-024-01645-8","volume":"43","author":"M Bhowmick","year":"2024","unstructured":"Bhowmick M, Sharma V. Cryptogenic multifocal ulcerous stenosing enteritis: A ray of light on the umbra of the dark continent. Indian J Gastroenterol. 2024;43:1082\u20135. https:\/\/doi.org\/10.1007\/s12664-024-01645-8.","journal-title":"Indian J Gastroenterol."},{"key":"1886_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12664-024-01698-9","volume":"44","author":"A Kumar","year":"2025","unstructured":"Kumar A, Sirwani J, Tripathy TP, et al. Chronic enteropathy associated with SLCO2A1 gene (CEAS) in Indian adolescents: Apropos of two cases. Indian J Gastroenterol. 2025;44:537\u20139. https:\/\/doi.org\/10.1007\/s12664-024-01698-9.","journal-title":"Indian J Gastroenterol."},{"key":"1886_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000546888","volume":"10","author":"J Umeno","year":"2025","unstructured":"Umeno J, Esaki M, Uchida K, Matsumoto T. Chronic enteropathy associated with SLCO2A1 gene. Inflamm Intest Dis. 2025;10:193\u2013203. https:\/\/doi.org\/10.1159\/000546888.","journal-title":"Inflamm Intest Dis."},{"key":"1886_CR56","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/gut.49.5.65025","volume":"49","author":"E Smecuol","year":"2001","unstructured":"Smecuol E, Bai JC, Sugai E, et al. Acute gastrointestinal permeability responses to different nonsteroidal anti-inflammatory drugs. Gut. 2001;49:650\u20135. https:\/\/doi.org\/10.1136\/gut.49.5.65025.","journal-title":"Gut."},{"key":"1886_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cca.2009.12.026","volume":"411","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K, Tanaka A, Kato S, et al. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta. 2010;411:459\u201366. https:\/\/doi.org\/10.1016\/j.cca.2009.12.026.","journal-title":"Clin Chim Acta."},{"key":"1886_CR58","first-page":"287","volume":"61","author":"Y Yoda","year":"2010","unstructured":"Yoda Y, Amagase K, Kato S, et al. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1. J Physiol Pharmacol. 2010;61:287\u201394.","journal-title":"J Physiol Pharmacol."},{"key":"1886_CR59","doi-asserted-by":"publisher","unstructured":"Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.\u00a0Gastroenterology. 2011;141:1314\u201322, 1322.e1\u20135.. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.075.","DOI":"10.1053\/j.gastro.2011.06.075"},{"key":"1886_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000308361","volume":"82","author":"S Fujimori","year":"2010","unstructured":"Fujimori S, Takahashi Y, Seo T, et al. Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy. Digestion. 2010;82:167\u201372. https:\/\/doi.org\/10.1159\/000308361.","journal-title":"Digestion."},{"key":"1886_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.mog.0000153314.51198.58","volume":"21","author":"PJ Fortun","year":"2005","unstructured":"Fortun PJ, Hawkey CJ. Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol. 2005;21:169\u201375. https:\/\/doi.org\/10.1097\/01.mog.0000153314.51198.58.","journal-title":"Curr Opin Gastroenterol."},{"key":"1886_CR62","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/BF02063257","volume":"40","author":"T Arakawa","year":"1995","unstructured":"Arakawa T, Watanabe T, Fukuda T, et al. Rebamipide, novel prostaglandininducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci. 1995;40:2469\u201372. https:\/\/doi.org\/10.1007\/BF02063257.","journal-title":"Comparison with cimetidine. Dig Dis Sci."},{"key":"1886_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00535-007-2155-4","volume":"43","author":"Y Niwa","year":"2008","unstructured":"Niwa Y, Nakamura M, Ohmiya N, et al. Efficacy of rebamipide for diclofenac-induced smallintestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol. 2008;43:270\u20136. https:\/\/doi.org\/10.1007\/s00535-007-2155-4.","journal-title":"J Gastroenterol."},{"key":"1886_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00535-010-0332-3","volume":"46","author":"S Fujimori","year":"2011","unstructured":"Fujimori S, Takahashi Y, Gudis K, et al. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. J Gastroenterol. 2011;46:57\u201364. https:\/\/doi.org\/10.1007\/s00535-010-0332-3.","journal-title":"J Gastroenterol."},{"key":"1886_CR65","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/art.1780370806","volume":"37","author":"J Hayllar","year":"1994","unstructured":"Hayllar J, Smith T, Macpherson A, et al. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum. 1994;37:1146\u201350. https:\/\/doi.org\/10.1002\/art.1780370806.","journal-title":"Arthritis Rheum."},{"key":"1886_CR66","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1348-0421.1998.tb02294.x","volume":"42","author":"T Kinouchi","year":"1998","unstructured":"Kinouchi T, Kataoka K, Bing SR, et al. Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation. Microbiol Immunol. 1998;42:347\u201355. https:\/\/doi.org\/10.1111\/j.1348-0421.1998.tb02294.x.","journal-title":"Microbiol Immunol."},{"key":"1886_CR67","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00535-011-0410-1","volume":"46","author":"H Endo","year":"2011","unstructured":"Endo H, Higurashi T, Hosono K, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011;46:894\u2013905. https:\/\/doi.org\/10.1007\/s00535-011-0410-1.","journal-title":"J Gastroenterol."},{"key":"1886_CR68","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2010.04324.x","volume":"32","author":"M Montalto","year":"2010","unstructured":"Montalto M, Gallo A, Curigliano V, et al. Clinical trial: the effects of a probiotic mixture on nonsteroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebocontrolled study. Aliment Pharmacol Ther. 2010;32:209\u201314. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04324.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"1886_CR69","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1053\/j.gastro.2016.12.007","volume":"152","author":"C Scarpignato","year":"2017","unstructured":"Scarpignato C, Dolak W, Lanas A, et al. Rifaximin reduces the number and severity of intestinal lesions associated with use of nonsteroidal anti-inflammatory drugs in humans. Gastroenterology. 2017;152:980\u201382.e3. https:\/\/doi.org\/10.1053\/j.gastro.2016.12.007.","journal-title":"Gastroenterology."},{"key":"1886_CR70","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/gut.33.9.1204","volume":"33","author":"I Bjarnason","year":"1992","unstructured":"Bjarnason I, Hayllar J, Smethurst P, et al. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992;33:1204\u20138. https:\/\/doi.org\/10.1136\/gut.33.9.1204.","journal-title":"Gut."},{"key":"1886_CR71","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/gut.52.11.1537","volume":"52","author":"CJ Hawkey","year":"2003","unstructured":"Hawkey CJ, Jones JI, Atherton CT, et al. Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut. 2003;52:1537\u201342. https:\/\/doi.org\/10.1136\/gut.52.11.1537.","journal-title":"Gut."},{"key":"1886_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/ars.2011.4351","volume":"17","author":"JL Wallace","year":"2012","unstructured":"Wallace JL, Ferraz JGP, Muscara MN. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid Redox Signal. 2012;17:58\u201367. https:\/\/doi.org\/10.1089\/ars.2011.4351.","journal-title":"Antioxid Redox Signal."},{"key":"1886_CR73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000339882","volume":"86","author":"YJ Lim","year":"2012","unstructured":"Lim YJ, Phan TM, Dial EJ, et al. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion. 2012;86:171\u20137. https:\/\/doi.org\/10.1159\/000339882.","journal-title":"Digestion."},{"key":"1886_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2036.2008.03765.x","volume":"28","author":"FL Lanza","year":"2008","unstructured":"Lanza FL, Marathi UK, Anand BS, Lichtenberger LM. Clinical trial: comparison of ibuprofenphosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients. Aliment Pharmacol Ther. 2008;28:431\u201342. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03765.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"1886_CR75","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1440-1746.2009.05929.x","volume":"24","author":"YJ Lim","year":"2009","unstructured":"Lim YJ, Lee JS, Ku YS, Hahm KB. Rescue strategies against non-steroidal anti-inflammatory druginduced gastroduodenal damage. J Gastroenterol Hepatol. 2009;24:1169\u201378. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05929.x.","journal-title":"J Gastroenterol Hepatol."},{"key":"1886_CR76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10620-015-3889-0","volume":"61","author":"H Satoh","year":"2016","unstructured":"Satoh H, Matsumoto H, Hirakawa T, Wada N. Soluble dietary fibers can protect the small intestinal mucosa without affecting the anti-inflammatory effect of indomethacin in adjuvant-induced arthritis rats. Dig Dis Sci. 2016;61:91\u20138. https:\/\/doi.org\/10.1007\/s10620-015-3889-0.","journal-title":"Dig Dis Sci."},{"key":"1886_CR77","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1046\/j.1365-2036.1999.00523.x","volume":"13","author":"ED Hond","year":"1999","unstructured":"Hond ED, Peeters M, Hiele M, et al. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Aliment Pharmacol Ther. 1999;13:679\u201385. https:\/\/doi.org\/10.1046\/j.1365-2036.1999.00523.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"1886_CR78","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.clnu.2005.04.004","volume":"24","author":"JW Kim","year":"2005","unstructured":"Kim JW, Jeon WK, Kim EJ. Combined effects of bovine colostrum and glutamine in diclofenacinduced bacterial translocation in rat. Clin Nutr Edinb Scotl. 2005;24:785\u201393. https:\/\/doi.org\/10.1016\/j.clnu.2005.04.004.","journal-title":"Clin Nutr Edinb Scotl."},{"key":"1886_CR79","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/sj.ejcn.1601727","volume":"57","author":"FJ Troost","year":"2003","unstructured":"Troost FJ, Saris WHM, Brummer RJM. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers. Eur J Clin Nutr. 2003;57:1579\u201385. https:\/\/doi.org\/10.1038\/sj.ejcn.1601727.","journal-title":"Eur J Clin Nutr."},{"key":"1886_CR80","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jep.2008.03.010","volume":"118","author":"HJ Song","year":"2008","unstructured":"Song HJ, Shin CY, Oh TY, Sohn UD. The protective effect of eupatilin on indomethacin-induced cell damage in cultured feline ileal smooth muscle cells: involvement of HO-1 and ERK. J Ethnopharmacol. 2008;118:94\u2013101. https:\/\/doi.org\/10.1016\/j.jep.2008.03.010.","journal-title":"J Ethnopharmacol."},{"key":"1886_CR81","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cgh.2008.06.021","volume":"6","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Sugimori S, Kameda N, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol. 2008;6:1279\u201382. https:\/\/doi.org\/10.1016\/j.cgh.2008.06.021.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1886_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000452361","volume":"95","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Masui A, Nakamura J, et al. Yogurt containing Lactobacillus gasseri mitigates aspirin-induced small bowel injuries: a prospective, randomized, double-blind, placebo-controlled trial. Digestion. 2017;95:49\u201354. https:\/\/doi.org\/10.1159\/000452361.","journal-title":"Digestion."},{"key":"1886_CR83","doi-asserted-by":"publisher","first-page":"40128","DOI":"10.1038\/srep40128","volume":"7","author":"Z Mujagic","year":"2017","unstructured":"Mujagic Z, de Vos P, Boekschoten MV, et al. The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Sci Rep. 2017;7:40128. https:\/\/doi.org\/10.1038\/srep40128.","journal-title":"Sci Rep."},{"key":"1886_CR84","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/s0016-5085(03)00171-9","volume":"124","author":"P Gionchetti","year":"2003","unstructured":"Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202\u20139. https:\/\/doi.org\/10.1016\/s0016-5085(03)00171-9.","journal-title":"Gastroenterology."},{"key":"1886_CR85","first-page":"627","volume":"2001","author":"RJ Playford","year":"1979","unstructured":"Playford RJ, MacDonald CE, Calnan DP, et al. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci. 1979;2001:627\u201333.","journal-title":"Clin Sci."},{"key":"1886_CR86","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/gut.49.5.650","volume":"49","author":"E Smecuol","year":"2001","unstructured":"Smecuol E, Bai JC, Sugai E, et al. Acute gastrointestinal permeability responses to different nonsteroidal anti-inflammatory drugs. Gut. 2001;49:650\u20135. https:\/\/doi.org\/10.1136\/gut.49.5.650.","journal-title":"Gut."},{"key":"1886_CR87","doi-asserted-by":"publisher","first-page":"E1043","DOI":"10.1055\/a-2155-8235","volume":"55","author":"J Xu","year":"2023","unstructured":"Xu J, Cai L, Cui B. Confocal laser endomicroscopy tears up the mask of protein-losing enteropathy. Endoscopy. 2023;55:E1043\u20134. https:\/\/doi.org\/10.1055\/a-2155-8235.","journal-title":"Endoscopy."}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01886-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:42:47Z","timestamp":1787132567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01886-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01886-1","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HS, TS, VM, JB, SB and MKG declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yes, by all authors.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members,\u00a0the Indian Society of Gastroenterology or the printer\/publishers are responsible for the results\/findings and content of this article.","order":3,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}]}}